Reuters logo
BRIEF-Beigene announces initiation of pivotal study in China
March 9, 2017 / 9:57 PM / 8 months ago

BRIEF-Beigene announces initiation of pivotal study in China

March 9 (Reuters) - Beigene Ltd:

* Beigene announces initiation of pivotal study in China with BTK inhibitor BGB-3111 in patients with relapsed or refractory CLL/SLL Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below